ABIGAIL CANNATA: Open Payments
NPI 1700586195 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 59 payments from 7 companies in 2025. Trend: 2023 $442 · 2024 $1,354 · 2025 $1,291
Food & beverage: $1,263Education: $28
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 19 | $434 |
| Gilead Sciences, Inc. | 15 | $375 |
| Merck Sharp & Dohme LLC | 10 | $187 |
| Insmed, Inc. | 8 | $158 |
| ABBVIE INC. | 3 | $61 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: CABENUVA, Biktarvy, Arikayce, RUKOBIA, ZERBAXA, PIFELTRO, NUZYRA, DALVANCE.
Industry payments across NC — which companies pay providers there.
